Net Cash Provided by (Used in) Operating Activities |
2.39M |
USD |
+5.47% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-905K |
USD |
+19.6% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
681K |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
20M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
7.75M |
shares |
+0.03% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0.1 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
2.16M |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
342K |
USD |
-81.4% |
Dec 31, 2023 |
Q4 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Dec 31, 2023 |
Q4 2023 |
Payments to Acquire Property, Plant, and Equipment |
11.1K |
USD |
-69.4% |
Mar 31, 2024 |
Q1 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
1.38M |
USD |
-92.2% |
Mar 31, 2024 |
Q1 2024 |
Deferred Income Tax Expense (Benefit) |
-852K |
USD |
-1484% |
Dec 31, 2023 |
Q4 2023 |
Current Income Tax Expense (Benefit) |
0 |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Unrecognized Tax Benefits |
0 |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Additional Paid in Capital |
23M |
USD |
+0.04% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
5.94M |
USD |
+6.48% |
Dec 31, 2023 |
Q4 2023 |